These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 33374253)

  • 1. Myeloid Cells in Glioblastoma Microenvironment.
    De Leo A; Ugolini A; Veglia F
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Myeloid Cells in GBM Immunosuppression.
    Lin YJ; Wu CY; Wu JY; Lim M
    Front Immunol; 2022; 13():887781. PubMed ID: 35711434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
    Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
    Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.
    Ye Z; Ai X; Zhao L; Fei F; Wang P; Zhou S
    Oncogene; 2021 Oct; 40(42):6059-6070. PubMed ID: 34556813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
    Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
    Front Immunol; 2022; 13():964898. PubMed ID: 35967394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
    Pires-Afonso Y; Niclou SP; Michelucci A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
    Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
    J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment.
    Codrici E; Popescu ID; Tanase C; Enciu AM
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies.
    Huang B; Zhang J; Zong W; Chen S; Zong Z; Zeng X; Zhang H
    Front Immunol; 2023; 14():994698. PubMed ID: 36923402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages and microglia: the cerberus of glioblastoma.
    Buonfiglioli A; Hambardzumyan D
    Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.
    Pang L; Khan F; Heimberger AB; Chen P
    Trends Cancer; 2022 Oct; 8(10):839-854. PubMed ID: 35624002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia-Centered Combinatorial Strategies Against Glioblastoma.
    Martins TA; Schmassmann P; Shekarian T; Boulay JL; Ritz MF; Zanganeh S; Vom Berg J; Hutter G
    Front Immunol; 2020; 11():571951. PubMed ID: 33117364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
    Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-neutrophil entanglement in glioblastoma.
    Friedmann-Morvinski D; Hambardzumyan D
    J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
    Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH
    PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
    Arrieta VA; Najem H; Petrosyan E; Lee-Chang C; Chen P; Sonabend AM; Heimberger AB
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma.
    Blank A; Kremenetskaia I; Urbantat RM; Acker G; Turkowski K; Radke J; Schneider UC; Vajkoczy P; Brandenburg S
    J Pathol; 2021 Feb; 253(2):160-173. PubMed ID: 33044746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.
    Ma J; Chen CC; Li M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of caveolin-1 restores myeloid cell function in human glioblastoma.
    Shimato S; Anderson LM; Asslaber M; Bruce JN; Canoll P; Anderson DE; Anderson RC
    PLoS One; 2013; 8(10):e77397. PubMed ID: 24130882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.